(Arylpiperazino-4-butyryl) -6 benzoxazolinones and reduction products: chemistry and pharmacodynamic study
Moussavi, Z.; Bonte, J.P.; Lesieur, D.; Leinot, M.; Lamar, J.C.; Tisne-Versailles, J.
Farmaco 44(1): 77-88
1989
ISSN/ISBN: 0014-827X PMID: 2742723 Document Number: 344116
The synthesis of various 6-(4-arylpiperazino-butyryl)-3-methyl-benzoxazolinones and their reduction products, 6-(4-arylpiperazino-1-hydroxy-butyl)-3-methyl-benzoxazolinones and 6-(4-arylpiperazino-butyl)-3 methyl-benzoxzolinones, is described. These compounds were tested for psychotropic and analgesic activities.
Document emailed within 1 workday
Related Documents
Krasnova, L.A.; Garcia-Rodriguez, L.C.; Shner, V.F.; Messinova, O.V.; Suvorov, N.N. 1974: Further study of the 20-ketosteroid reduction reactions of Bacillus megaterium strain VNIKhFI-1 (All-Union Chemistry and Pharmaceuticals Research Institute) Prikladnaia Biokhimiia i Mikrobiologiia 10(6): 805-810Toledano, A.; Martinez-Rodriguez, R. 1972: Study of the hydrolysis of acetyl- and butyryl thiocholine in cerebellum of rat using a new histochemical technique (menadione-NBT) Annales d'Histochimie 17(4): 289-304
Dybkaer, R. 1979: International Union of Pure and Applied Chemistry and International Federation of Clinical Chemistry. IUPAC Section on Clinical Chemistry Commission on Quantities and Units in Clinical Chemistry and IFCC Committee on Standards Expert Panel on Quantities and Units approved recommendation (1978). List of quantities in clinical chemistry Journal of Clinical Chemistry and Clinical Biochemistry 17(12): 822-835
Parker, L.T.; Deng, Q.; Zakeri, H.; Carlson, C.; Nickerson, D.A.; Kwok, P.Y. 1995: Peak height variations in automated sequencing of PCR products using Taq dye-terminator chemistry Biotechniques 19(1): 116-121
Hoiberg, C.P. 1989: Aluminum in parenteral products: overview of chemistry concerns and regulatory actions Journal of Parenteral Science and Technology: a Publication of the Parenteral Drug Association 43(3): 127-131
Brånstad, J.O. 1970: Hydrolysis of some 2-benzoxazolinones Acta Pharmaceutica Suecica 7(3): 303-317
Schaufelberger, D.E. 1991: Applications of analytical high-speed counter-current chromatography in natural products chemistry Journal of Chromatography 538(1): 45-57
Yu, D.Q.; Chen, Y.; Liang, X.T. 2000: Structural chemistry and biological activities of natural products from Chinese herbal medicines--part Ii Research Communications in Molecular Pathology and Pharmacology 107(5-6): 431-459
Boonkitticharoen, V.; Puchinda, D.; Ayudhya, A.N.; Kraiphibul, P. 2001: Factors affecting chemistry of reduction-mediated 99mTc-labelling of monoclonal antibodies and polyclonal human immunoglobulins Journal of the Medical Association of Thailand 84(4): 545-553
Malspeis, L.; Bathala, M.S.; Ludden, T.M.; Bhat, H.B.; Frank, S.G.; Sokoloski, T.D.; Morrison, B.E.; Reuning, R.H. 1975: Metabolic reduction of naltrexone. I. Synthesis, separation and characterization of naloxone and naltrexone reduction products and qualitative assay of urine and bile following administration of naltrexone, alpha-naltrexol, or beta-naltrexol Research Communications in Chemical Pathology and Pharmacology 12(1): 43-65
Yankell, S.L.; Shi, X.; Spirgel, C.M.; Gonzalez, L.A.; Cwik, J. 2019: Laboratory plaque reduction by three floss products American Journal of Dentistry 32(6): 267-270
Kawasaki, N.; Ohta, M.; Hyuga, S.; Hashimoto, O.; Morimoto, K.; Hayakawa, T. 1998: Study on evaluating methods for the quality control of glycoprotein products. (II)--Erythropoietin products. Part 2 Kokuritsu Iyakuhin Shokuhin Eisei Kenkyujo Hokoku 116: 117-121
Itoh, S.; Kawasaki, N.; Ohta, M.; Hyuga, M.; Hyuga, S.; Hayakawa, T. 2001: Study on evaluating methods for the quality control of glycoprotein products. (III)--Erythropoietin products. Part 3 Kokuritsu Iyakuhin Shokuhin Eisei Kenkyujo Hokoku 119: 65-69
Romanova, A.K.; Vedenina, I.I.; Nozhevnikova, A.N. 1970: Short-term chemosynthesis products and some enzymes of the reduction pentosephosphate cycle in Hydrogenomonas eutropha Mikrobiologiia 39(4): 557-561
Chen, J.K.; Song, S.; Yang, P.J.; He, M.L.; Fan, S.B.; Li, L.M.; Gui, Y.L.; Fotherby, K. 1990: A pharmacodynamic and pharmacokinetic study of the Chinese No. 1 pill Contraception 42(4): 439-453
Cuenca, E.; Alamo, C.; Serrano, M.I.; Casais, L. 1978: Pharmacodynamic study of (M-14012-4) N-(4-picolyl)-3,5-dimethylbenzamide Archivos de Farmacologia y Toxicologia 4(1): 143-145
Alvarez Gómez, J.A.; Gil Sánchez, J.C.; Brugger, A.J. 1987: Comparative experimental pharmacodynamic study of different neuromuscular blockers Revista Espanola de Anestesiologia y Reanimacion 34(1): 2-10
Paradelis, A.G.; Tzouveleki, M.; Kouvelas, D.; Salpigides, G.; Pangalis, A.; Crassaris, L.G. 1995: Quinolones and serum butyryl-cholinesterase activity Journal of ChemoTherapy 7(Suppl 4): 34-35
Gilbert, J.C.; Weissenburger, J.; Rozensztajn, L.; Jaillon, P.; Cheymol, G. 1975: Pharmacodynamic study of supraventricular tachycardia in the human. Beneficial role of atropine Therapie 30(6): 809-814
Campa, P.P.; Silverii, A.; Tomassini, P.; Bonolis, G. 1973: Pharmacodynamic study on the acoustic "cannon sound" findings; physiopathological considerations Bollettino Della Societa Italiana di Cardiologia 18(12): 1241-1251